146 related articles for article (PubMed ID: 7384094)
61. Development and characteristics of the available animal model systems for the study of prostatic cancer.
Isaacs JT
Prog Clin Biol Res; 1987; 239():513-76. PubMed ID: 3309963
[No Abstract] [Full Text] [Related]
62. Metastasis of rat prostate adenocarcinoma cells.
Pollard M; Chan SY
Prog Clin Biol Res; 1981; 75B():249-56. PubMed ID: 6798581
[No Abstract] [Full Text] [Related]
63. New principles in the management of metastatic prostatic cancer.
Isaacs JT
Prog Clin Biol Res; 1985; 185A():383-405. PubMed ID: 4034581
[No Abstract] [Full Text] [Related]
64. Studies on a weakly immunogenic squamous cell carcinoma of the rat prostate.
Lande IJ; Feldbush TL; Lubaroff DM
Invest Urol; 1980 Mar; 17(5):419-24. PubMed ID: 7358506
[TBL] [Abstract][Full Text] [Related]
65. Experimental models for the study of prostatic adenocarcinoma.
Smolev JK; Coffey DS; Scott WW
J Urol; 1977 Jul; 118(1 Pt 2):216-20. PubMed ID: 875219
[TBL] [Abstract][Full Text] [Related]
66. Cell kinetic studies of prostatic cancer: adjuvant therapy in animal models.
Weissman RM; Coffey DS; Scott WW
Oncology; 1977; 34(3):133-7. PubMed ID: 917443
[TBL] [Abstract][Full Text] [Related]
67. [The place of hormonotherapy in cancerology].
Cah Med; 1972 Apr; 13(5):392-4. PubMed ID: 5055116
[No Abstract] [Full Text] [Related]
68. Animal models for tumor progression (short review).
Leibovici J; Wolman M
Anticancer Res; 1984; 4(3):165-8. PubMed ID: 6380399
[TBL] [Abstract][Full Text] [Related]
69. Mammary carcinoma in the cat a model in comparative cancer research?
Weijer K; Hampe JF; Misdorp W
Arch Chir Neerl; 1973; 25(4):413-25. PubMed ID: 4771978
[No Abstract] [Full Text] [Related]
70. An experimental model for mouse prostatic hyperplasia: characterization of hormonal, age and tissue specificities.
Chung LW; Auble K
Proc West Pharmacol Soc; 1985; 28():35-9. PubMed ID: 2415986
[No Abstract] [Full Text] [Related]
71. In vitro models for prostatic cancer: summary.
Webber MM
Prog Clin Biol Res; 1980; 37():133-47. PubMed ID: 7384083
[No Abstract] [Full Text] [Related]
72. Nb rat prostate adenocarcinoma model androgen-sensitive tumor: metastasis control.
Drago JR; Weed P; Fralisch A
J Surg Oncol; 1983 Sep; 24(1):33-5. PubMed ID: 6887934
[TBL] [Abstract][Full Text] [Related]
73. Introduction: attributes of human cancer to be considered in seeking animal models.
Woodruff MF
Br J Radiol; 1971 Nov; 44(527):904. PubMed ID: 5123614
[No Abstract] [Full Text] [Related]
74. Natural history of prostatic cancer.
Whitmore WF
Prog Clin Biol Res; 1984; 153():447-54. PubMed ID: 6473407
[No Abstract] [Full Text] [Related]
75. Prostate cancer.
Schroeder FH
J Urol; 1995 May; 153(5):1592-3. PubMed ID: 7714979
[No Abstract] [Full Text] [Related]
76. Human malignancy-associated nucleolar antigen (HuMANA) and zinc in human prostatic tissues.
Gyorkey F
Prog Clin Biol Res; 1981; 75A():491-502. PubMed ID: 7041135
[No Abstract] [Full Text] [Related]
77. Animal models in the study of antiprostatic drugs.
Neumann F; Richter KD; Senge TH
Vitam Horm; 1975; 33():103-35. PubMed ID: 59459
[No Abstract] [Full Text] [Related]
78. [Prostatic cancer--current therapeutic trend].
Kato A; Takahashi Y
Nihon Rinsho; 1970 Mar; 28 Suppl():1166-7. PubMed ID: 5430816
[No Abstract] [Full Text] [Related]
79. Cell motility as an index of metastatic ability in prostate cancers: results with an animal model and with human cancer cells.
Partin AW; Mohler JL; Coffey DS
Cancer Treat Res; 1992; 59():121-30. PubMed ID: 1347689
[No Abstract] [Full Text] [Related]
80. [The role of beta-glucuronidase in the tumor process and cancer prevention].
Vlasov NN; Pliss GB
Vopr Onkol; 1990; 36(9):1037-44. PubMed ID: 2238544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
